 4-MAR-1987 17:07:06.01

HUNTERDON <HUNT> SETS DENTAL VENTURE

Hunterdon Pharmaceuticals Inc said it formed a joint venture with <Chesapeake Biological Laboratories> and <E.B. Michaels Research Associates> to develop C31G, a substance that may be useful in the treatment or prevention of plaque.
 The substance, tested in pre-clinical trials at the University of Pennsylvania, also has other uses as an anti-fungal or anti-bacterial agent, the company said.
 It said Chesapeake Biological, a private company, owns 55 pct of the venture, E.B. Michaels 10 pct, while it holds the remaining interest, and the patent for C31G.  Reuter &#3;

